Skip to main content

Novo Nordisk A S

NONOF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0000353278

No open-market purchases or sales by Novo Nordisk A S insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $5.36M in total; no superinvestor holds it.

Other share classesNVO

Superinvestors holding NONOF, Q2 2026

See all superinvestors

No superinvestor reported holding NONOF in Q2 2026.